Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases.

The Fungitell assay (FA) and the Wako β-glucan test (GT) are employed to measure the serum/plasma 1,3-β-D-glucan (BDG), a well-known invasive fungal disease biomarker. Data to convincingly and/or sufficiently support the GT as a valuable alternative to the FA are yet limited. In this study, we evalu...

Full description

Bibliographic Details
Main Authors: Elena De Carolis, Federica Marchionni, Riccardo Torelli, Morandotti Grazia Angela, Livio Pagano, Rita Murri, Gennaro De Pascale, Giulia De Angelis, Maurizio Sanguinetti, Brunella Posteraro
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0236095
id doaj-4c4009fa8c91480396b2b92146ca650d
record_format Article
spelling doaj-4c4009fa8c91480396b2b92146ca650d2021-03-03T21:56:41ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-01157e023609510.1371/journal.pone.0236095Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases.Elena De CarolisFederica MarchionniRiccardo TorelliMorandotti Grazia AngelaLivio PaganoRita MurriGennaro De PascaleGiulia De AngelisMaurizio SanguinettiBrunella PosteraroThe Fungitell assay (FA) and the Wako β-glucan test (GT) are employed to measure the serum/plasma 1,3-β-D-glucan (BDG), a well-known invasive fungal disease biomarker. Data to convincingly and/or sufficiently support the GT as a valuable alternative to the FA are yet limited. In this study, we evaluated the FA and the GT to diagnose invasive aspergillosis (IA), invasive candidiasis (IC), and Pneumocystis jirovecii pneumonia (PJP). The FA and GT performances were compared in sera of patients with IA (n = 40), IC (n = 78), and PJP (n = 17) with respect to sera of control patients (n = 187). Using the manufacturer's cutoff values of 80 pg/mL and 11 pg/mL, the sensitivity and specificity for IA diagnosis were 92.5% and 99.5% for the FA and 60.0% and 99.5% for the GT, respectively; for IC diagnosis were 100.0% and 97.3% for the FA and 91.0% and 99.5% for the GT, respectively; for PJP diagnosis were 100.0% and 97.3% for the FA and 88.2% and 99.5% for the GT, respectively. When an optimized cutoff value of 7.0 pg/mL for the GT was used, the sensitivity and specificity were 80.0% and 97.3% for IA diagnosis, 98.7% and 97.3% for IC diagnosis, and 94.1% and 97.3% for PJP diagnosis, respectively. At the 7.0-pg/mL GT cutoff, the agreement between the assays remained and/or became excellent for IA (95.1%), IC (97.3%), and PJP (96.5%), respectively. In conclusion, we show that the GT performed as well as the FA only with a lowered cutoff value for positivity. Further studies are expected to establish the equivalence of the two BDG assays.https://doi.org/10.1371/journal.pone.0236095
collection DOAJ
language English
format Article
sources DOAJ
author Elena De Carolis
Federica Marchionni
Riccardo Torelli
Morandotti Grazia Angela
Livio Pagano
Rita Murri
Gennaro De Pascale
Giulia De Angelis
Maurizio Sanguinetti
Brunella Posteraro
spellingShingle Elena De Carolis
Federica Marchionni
Riccardo Torelli
Morandotti Grazia Angela
Livio Pagano
Rita Murri
Gennaro De Pascale
Giulia De Angelis
Maurizio Sanguinetti
Brunella Posteraro
Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases.
PLoS ONE
author_facet Elena De Carolis
Federica Marchionni
Riccardo Torelli
Morandotti Grazia Angela
Livio Pagano
Rita Murri
Gennaro De Pascale
Giulia De Angelis
Maurizio Sanguinetti
Brunella Posteraro
author_sort Elena De Carolis
title Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases.
title_short Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases.
title_full Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases.
title_fullStr Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases.
title_full_unstemmed Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases.
title_sort comparative performance evaluation of wako β-glucan test and fungitell assay for the diagnosis of invasive fungal diseases.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2020-01-01
description The Fungitell assay (FA) and the Wako β-glucan test (GT) are employed to measure the serum/plasma 1,3-β-D-glucan (BDG), a well-known invasive fungal disease biomarker. Data to convincingly and/or sufficiently support the GT as a valuable alternative to the FA are yet limited. In this study, we evaluated the FA and the GT to diagnose invasive aspergillosis (IA), invasive candidiasis (IC), and Pneumocystis jirovecii pneumonia (PJP). The FA and GT performances were compared in sera of patients with IA (n = 40), IC (n = 78), and PJP (n = 17) with respect to sera of control patients (n = 187). Using the manufacturer's cutoff values of 80 pg/mL and 11 pg/mL, the sensitivity and specificity for IA diagnosis were 92.5% and 99.5% for the FA and 60.0% and 99.5% for the GT, respectively; for IC diagnosis were 100.0% and 97.3% for the FA and 91.0% and 99.5% for the GT, respectively; for PJP diagnosis were 100.0% and 97.3% for the FA and 88.2% and 99.5% for the GT, respectively. When an optimized cutoff value of 7.0 pg/mL for the GT was used, the sensitivity and specificity were 80.0% and 97.3% for IA diagnosis, 98.7% and 97.3% for IC diagnosis, and 94.1% and 97.3% for PJP diagnosis, respectively. At the 7.0-pg/mL GT cutoff, the agreement between the assays remained and/or became excellent for IA (95.1%), IC (97.3%), and PJP (96.5%), respectively. In conclusion, we show that the GT performed as well as the FA only with a lowered cutoff value for positivity. Further studies are expected to establish the equivalence of the two BDG assays.
url https://doi.org/10.1371/journal.pone.0236095
work_keys_str_mv AT elenadecarolis comparativeperformanceevaluationofwakobglucantestandfungitellassayforthediagnosisofinvasivefungaldiseases
AT federicamarchionni comparativeperformanceevaluationofwakobglucantestandfungitellassayforthediagnosisofinvasivefungaldiseases
AT riccardotorelli comparativeperformanceevaluationofwakobglucantestandfungitellassayforthediagnosisofinvasivefungaldiseases
AT morandottigraziaangela comparativeperformanceevaluationofwakobglucantestandfungitellassayforthediagnosisofinvasivefungaldiseases
AT liviopagano comparativeperformanceevaluationofwakobglucantestandfungitellassayforthediagnosisofinvasivefungaldiseases
AT ritamurri comparativeperformanceevaluationofwakobglucantestandfungitellassayforthediagnosisofinvasivefungaldiseases
AT gennarodepascale comparativeperformanceevaluationofwakobglucantestandfungitellassayforthediagnosisofinvasivefungaldiseases
AT giuliadeangelis comparativeperformanceevaluationofwakobglucantestandfungitellassayforthediagnosisofinvasivefungaldiseases
AT mauriziosanguinetti comparativeperformanceevaluationofwakobglucantestandfungitellassayforthediagnosisofinvasivefungaldiseases
AT brunellaposteraro comparativeperformanceevaluationofwakobglucantestandfungitellassayforthediagnosisofinvasivefungaldiseases
_version_ 1714814172995256320